Skip to main content
Erschienen in: International Urogynecology Journal 12/2016

18.03.2016 | Review Article

Female pelvic organ prolapse using pessaries: systematic review

verfasst von: Suelene Costa de Albuquerque Coelho, Edilson Benedito de Castro, Cássia Raquel Teatin Juliato

Erschienen in: International Urogynecology Journal | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The purpose of this systematic review is to assess the impact of pessary use on the quality of life of women with pelvic organ prolapse, and to determine the satisfaction rate and rationale for discontinuation.

Methods

This review is recorded in the PROSPERO database under number CRD42015023384. The criteria for inclusion were observational study; cross section; cohort study; randomized controlled trial; study published in English, Portuguese, and Spanish; and study whose participants are women with female pelvic organ prolapse treated using a pessary. We did not include limitations on the year of publication. The criteria for exclusion included studies that did not include the topic, bibliographic or systematic reviews and articles that did not use validated questionnaires. The MeSH terms were “Pelvic Organ Prolapse AND Pessaries AND Quality of Life” OR “Pessary AND Quality of Life” OR “Pessaries”.

Results

We found 89 articles. After the final analyses, seven articles were included. All articles associated pessary use with improved quality of life, and all used only validated questionnaires. Over half of the women continued using the pessary during the follow-up with acceptable levels of satisfaction. The main rationales for discontinuation were discomfort, pain in the area, and expulsion of the device.

Conclusion

This systematic review demonstrates that the pessary can produce a positive effect on women’s quality of life and can significantly improve sexual function and body perception.
Literatur
1.
Zurück zum Zitat Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26CrossRefPubMed Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26CrossRefPubMed
2.
Zurück zum Zitat Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 16(3):176–181, discussion 81CrossRefPubMed Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 16(3):176–181, discussion 81CrossRefPubMed
3.
Zurück zum Zitat Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184(7):1496–1501, discussion 501–503 Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184(7):1496–1501, discussion 501–503
4.
Zurück zum Zitat Wiskind AK, Creighton SM, Stanton SL (1992) The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol 167(2):399–404, discussion 405CrossRefPubMed Wiskind AK, Creighton SM, Stanton SL (1992) The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol 167(2):399–404, discussion 405CrossRefPubMed
5.
Zurück zum Zitat Kjølhede P, Norén B, Rydén G (1996) Prediction of genital prolapse after Burch colposuspension. Acta Obstet Gynecol Scand 75(9):849–854CrossRefPubMed Kjølhede P, Norén B, Rydén G (1996) Prediction of genital prolapse after Burch colposuspension. Acta Obstet Gynecol Scand 75(9):849–854CrossRefPubMed
6.
Zurück zum Zitat Braekken IH, Majida M, Engh ME, Bø K (2010) Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol 203(2):170.e1–170.e7CrossRef Braekken IH, Majida M, Engh ME, Bø K (2010) Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol 203(2):170.e1–170.e7CrossRef
7.
Zurück zum Zitat McIntosh L (2005) The role of the nurse in the use of vaginal pessaries to treat pelvic organ prolapse and/or urinary incontinence: a literature review. Urol Nurs 25(1):41–48PubMed McIntosh L (2005) The role of the nurse in the use of vaginal pessaries to treat pelvic organ prolapse and/or urinary incontinence: a literature review. Urol Nurs 25(1):41–48PubMed
8.
Zurück zum Zitat Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M (2005) Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct 16(6):497–503CrossRefPubMed Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M (2005) Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct 16(6):497–503CrossRefPubMed
9.
Zurück zum Zitat Woodman PJ, Swift SE, O’Boyle AL, Valley MT, Bland DR, Kahn MA et al (2006) Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct 17(4):340–345CrossRefPubMed Woodman PJ, Swift SE, O’Boyle AL, Valley MT, Bland DR, Kahn MA et al (2006) Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct 17(4):340–345CrossRefPubMed
10.
Zurück zum Zitat Manchana T (2011) Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet 284(2):391–395CrossRefPubMed Manchana T (2011) Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet 284(2):391–395CrossRefPubMed
11.
Zurück zum Zitat Mutone MF, Terry C, Hale DS, Benson JT (2005) Factors which influence the short-term success of pessary management of pelvic organ prolapse. Am J Obstet Gynecol 193(1):89–94CrossRefPubMed Mutone MF, Terry C, Hale DS, Benson JT (2005) Factors which influence the short-term success of pessary management of pelvic organ prolapse. Am J Obstet Gynecol 193(1):89–94CrossRefPubMed
12.
Zurück zum Zitat Lamers BH, Broekman BM, Milani AL (2011) Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J 22(6):637–644CrossRefPubMedPubMedCentral Lamers BH, Broekman BM, Milani AL (2011) Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J 22(6):637–644CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784CrossRefPubMed Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784CrossRefPubMed
14.
Zurück zum Zitat Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B et al (2016) ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol 69:225–234 Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B et al (2016) ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol 69:225–234
15.
Zurück zum Zitat Patel M, Mellen C, O’Sullivan DM, LaSala CA (2010) Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol 202(5):499.e1–499.e4CrossRef Patel M, Mellen C, O’Sullivan DM, LaSala CA (2010) Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol 202(5):499.e1–499.e4CrossRef
16.
Zurück zum Zitat Mamik MM, Rogers RG, Qualls CR, Komesu YM (2013) Goal attainment after treatment in patients with symptomatic pelvic organ prolapse. Am J Obstet Gynecol 209(5):488.e1–488.e5CrossRef Mamik MM, Rogers RG, Qualls CR, Komesu YM (2013) Goal attainment after treatment in patients with symptomatic pelvic organ prolapse. Am J Obstet Gynecol 209(5):488.e1–488.e5CrossRef
17.
Zurück zum Zitat Kuhn A, Bapst D, Stadlmayr W, Vits K, Mueller MD (2009) Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful? Fertil Steril 91(5):1914–1918CrossRefPubMed Kuhn A, Bapst D, Stadlmayr W, Vits K, Mueller MD (2009) Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful? Fertil Steril 91(5):1914–1918CrossRefPubMed
18.
Zurück zum Zitat Cundiff GW, Amundsen CL, Bent AE, Coates KW, Schaffer JI, Strohbehn K et al (2007) The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol 196(4):405.e1–405.e8CrossRef Cundiff GW, Amundsen CL, Bent AE, Coates KW, Schaffer JI, Strohbehn K et al (2007) The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol 196(4):405.e1–405.e8CrossRef
19.
Zurück zum Zitat Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR et al (2007) Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol 197(6):620.e1–620.e6CrossRef Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR et al (2007) Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol 197(6):620.e1–620.e6CrossRef
20.
Zurück zum Zitat Abdool Z, Thakar R, Sultan AH, Oliver RS (2011) Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J 22(3):273–278CrossRefPubMed Abdool Z, Thakar R, Sultan AH, Oliver RS (2011) Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J 22(3):273–278CrossRefPubMed
21.
Zurück zum Zitat Lone F, Thakar R, Sultan AH (2015) One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires. Int Urogynecol J 26(9):1305–1312 Lone F, Thakar R, Sultan AH (2015) One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires. Int Urogynecol J 26(9):1305–1312
22.
Zurück zum Zitat Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW (2006) Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol 108(1):93–99CrossRefPubMed Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW (2006) Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol 108(1):93–99CrossRefPubMed
23.
Zurück zum Zitat Chan SS, Cheung RY, Yiu KW, Lee LL, Pang AW, Chung TK (2012) Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J 23(8):1027–1033 Chan SS, Cheung RY, Yiu KW, Lee LL, Pang AW, Chung TK (2012) Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J 23(8):1027–1033
24.
Zurück zum Zitat Kapoor DS, Freeman RM (2009) Reoperation rate following prolapse surgery. Am J Obstet Gynecol 200(2):e15, author reply e15CrossRefPubMed Kapoor DS, Freeman RM (2009) Reoperation rate following prolapse surgery. Am J Obstet Gynecol 200(2):e15, author reply e15CrossRefPubMed
26.
Zurück zum Zitat Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL (2004) Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 190(4):1025–1029CrossRefPubMed Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL (2004) Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 190(4):1025–1029CrossRefPubMed
27.
Zurück zum Zitat Maito JM, Quam ZA, Craig E, Danner KA, Rogers RG (2006) Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health 51(2):78–84CrossRefPubMed Maito JM, Quam ZA, Craig E, Danner KA, Rogers RG (2006) Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health 51(2):78–84CrossRefPubMed
28.
Zurück zum Zitat Robert M, Schulz JA, Harvey MA, Lovatsis D, Walter JE, Chou Q et al (2013) Technical update on pessary use. J Obstet Gynaecol Can 35(7):664–674CrossRefPubMed Robert M, Schulz JA, Harvey MA, Lovatsis D, Walter JE, Chou Q et al (2013) Technical update on pessary use. J Obstet Gynaecol Can 35(7):664–674CrossRefPubMed
Metadaten
Titel
Female pelvic organ prolapse using pessaries: systematic review
verfasst von
Suelene Costa de Albuquerque Coelho
Edilson Benedito de Castro
Cássia Raquel Teatin Juliato
Publikationsdatum
18.03.2016
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 12/2016
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-016-2991-y

Weitere Artikel der Ausgabe 12/2016

International Urogynecology Journal 12/2016 Zur Ausgabe

Letter to the Editor

Reply to the Editor

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.